Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001199835-22-000830
Filing Date
2022-12-19
Accepted
2022-12-19 16:39:21
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 09/30/2021 10-K pkph093021-10k.htm   iXBRL 10-K 629821
2 PROMISSORY NOTE DATED JULY 6, 2021 WITH CHURCH & KEELER, INC. pkph093021-ex10_10.htm EX-10.10 58242
3 PROMISSORY NOTE DATED JULY 6, 2021 WITH DRAPER, INC. pkph093021-ex10_11.htm EX-10.11 58180
4 PROMISSORY NOTE DATED JULY 6, 2021 WITH HAPPY DAVID WALTERS pkph093021-ex10_12.htm EX-10.12 58200
5 PROMISSORY NOTE DATED JULY 9, 2021 WITH CARRIAGE HOUSE CAPITAL, INC. pkph093021-ex10_13.htm EX-10.13 58212
6 PROMISSORY NOTE DATED JULY 22, 2021 WITH JOHN WALTERS NICK, JR. pkph093021-ex10_14.htm EX-10.14 58191
7 PROMISSORY NOTE DATED JULY 22, 2021 WITH GARY GOODMAN pkph093021-ex10_15.htm EX-10.15 58206
8 PROMISSORY NOTE DATED JULY 26, 2021 WITH STEFAN GALLUPPI pkph093021-ex10_16.htm EX-10.16 58205
9 PROMISSORY NOTE DATED AUGUST 4, 2021 WITH JUSTIN SCHREIBER pkph093021-ex10_17.htm EX-10.17 55965
10 PROMISSORY NOTE DATED AUGUST 6, 2021 WITH ALEXANDER LIMITED pkph093021-ex10_18.htm EX-10.18 58217
11 PROMISSORY NOTE DATED AUGUST 12, 2021 WITH ALIUNDE LIMITED pkph093021-ex10_19.htm EX-10.19 58263
12 PROMISSORY NOTE DATED SEPTEMBER 28, 2021 WITH NEIL REITHINGER pkph093021-ex10_20.htm EX-10.20 56782
13 CERTIFICATION pkph093021-ex31_1.htm EX-31.1 16701
14 CERTIFICATION pkph093021-ex31_2.htm EX-31.2 17316
15 CERTIFICATION pkph093021-ex32_1.htm EX-32.1 5526
16 CERTIFICATION pkph093021-ex32_2.htm EX-32.2 5653
22 GRAPHIC pp001_v1.jpg GRAPHIC 3815
23 GRAPHIC pp002_v1.jpg GRAPHIC 4198
  Complete submission text file 0001199835-22-000830.txt   3104927

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE pkph-20210930.xsd EX-101.SCH 17286
18 XBRL CALCULATION FILE pkph-20210930_cal.xml EX-101.CAL 19989
19 XBRL DEFINITION FILE pkph-20210930_def.xml EX-101.DEF 44285
20 XBRL LABEL FILE pkph-20210930_lab.xml EX-101.LAB 142586
21 XBRL PRESENTATION FILE pkph-20210930_pre.xml EX-101.PRE 119434
50 EXTRACTED XBRL INSTANCE DOCUMENT pkph093021-10k_htm.xml XML 209592
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53855 | Film No.: 221471604
SIC: 2834 Pharmaceutical Preparations